References
- Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine20, 1831–1836 (2002).
- Potter C. A history of influenza. J. Appl. Microbiol.91, 572–579 (2001).
- Ansaldi F, Bacilieri S, Banfi F et al. Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004–2005 influenza vaccine against drifted viruses. Clin. Vaccine Immunol.13, 162–164 (2006).
- Nichols K. Cost benefit analysis of a strategy for healthy working adults against influenza. Arch. Intern. Med.161, 749–759 (2001).
- Grau A, Fischer B, Barth C et al. Influenza vaccination is associated with a reduced risk of stroke. Stroke36, 1501–1506 (2005).
- Nichol K, Nordin J, Mullooly J et al. Influenza vaccination and reduction in hospitalization for cardiac disease and stroke among the elderly. N. Engl. J. Med.348, 1322–1332 (2003).
- Nichol K. The efficacy, effectiveness and cost–effectiveness of inactivated influenza virus vaccines. Vaccine21, 1769–1775 (2003).
- Armstrong B, Mangtani P, Fletcher A et al. Effect of influenza vaccination on excess deaths during periods of high circulation of influenza: cohort study in elderly people. Br. Med. J.329, 660 (2004).
- Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine24, 1159–1169 (2006).
- McElhaney J. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine23(Suppl. 1), S10–S25 (2005).
- Simonsen L, Reichert T, Viboud C et al. Impact of influenza vaccination on seasonal mortality in the us elderly population. Arch. Intern. Med.165, 265–272 (2005).
- Jefferson T, Rivetti D, Rudin M, Di Pierantoni C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet366, 1165–1174 (2005).
- Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59C.1-adjuvanted vaccine. Vaccine19, 2673–2680 (2001).
- Banzhoff A, Nacci P, Podda A. A new MF59-adjuvanted influenza vaccine enhances the immune repose in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology49, 177–184 (2003).
- Puig-Barbera J, Diez-Domingo J, Perez Hoyos S, Belenguer Varea A, Gonzales Vidal D. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine23, 283–289 (2004).
- Iob A, Brianti G, Zamparo E, Gallo T. Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiol. Infect.133, 687–693 (2005).
- Baldo V, Menegon T, Bonello C, Floreani A, Trivello R, Collaborative Group. Comparison of three different influenza vaccines in institutionalized elderly. Vaccine19, 3472–3425 (2001).
- Menegon T, Baldo V, Bonello C, Dalla Costa D, Di Tommaso A, Trivello R. Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population. Eur. J. Epidemiol.15, 573–576 (1999).
- Minutello M, Senatore F, Cecchinelli G et al. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59C.1 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine17, 99–104 (1999).
- De Donato S, Granoff D, Minutello M et al. Safety and immunogenicity of MF59C.1-adjuvanted influenza vaccine in the elderly. Vaccine17, 3094–3101 (1999).
- Piercy J, Ryan J, Megas F. Economic evaluation of MF59 adjuvanted vaccine against influenza in the high-risk elderly population in France. J. Med. Econ.7, 1–18 (2004).
- Pearl J. Probabilistic reasoning in intelligent systems: In: Networks of Plausible Inference. Morgan Kauffman, CA, USA (1988).
- Eddy D, Hasselblad V, Shachter R. A Bayesian method for synthesizing evidence: the confidence profile method. Int. J. Technol. Assess. Health Care6, 31–55 (1990).
- Szolovits P. Uncertainty and decisions in medical informatics. Methods Inf. Med.34, 111–121 (1995).
- Owens D, Shachter R, Nease R. Representation and analysis of medical decision problems with influence diagrams. Med. Decis. Making17, 241–262 (1997).
- Parmigiani G. Modeling in Medical Decision Making. John Wiley and Sons, NY, USA (2002).
- Spiegelhalter D, Abrams K, Myles J. Bayesian Approaches To Clinical Trials And Health-Care Evaluation. John Wiley and Sons, Chichester, UK (2004).
- Spiegelhalter D, Dawid P, Lauritzen S, Cowell R. Bayesian analysis in expert systems. Stat. Sci.8, 219–283 (1993).
- Howard R, Matheson J. Readings in Decision Analysis. Strategic Decision Group, CA, USA (1981)
- Shenoy P. A comparison of graphical techniques for decision analysis. Eur. J. Oper. Res.78, 1–21 (1994)
- Scuffham P, West P. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine20, 2562–2578 (2002).
- Gasparini R, Lucioni C, Mazzi S, Pregliasco F. Vaccino adiuvato virosomale vs vaccino tradizionale nella strategia antinfluenzale: una valutazione farmacoeconomica. Pharmacoeconomics Issues Vaccines Adis International ISBN 88-88371-22-2 (2002).
- Regione Friuli. Rapporto sulla vaccinazione contro l’influenza nella popolazione anziana nella stagione 1997–1998 (1999)
- Crocetti E, Arniani S, Bordoni F et al. Effectiveness of influenza vaccination in the elderly in a community in Italy. Eur. J. Epidemiol.17, 163–168 (2001).
- Gasparini R, Lucioni C, Lai P, De Luca S et al. Influenza surveillance in the Italian region of Liguria in the winter 1999–2000 by general pratictioners and paeditricians: socio-economic implications. J. Prev. Med. Hyg.42, 83–86 (2001).
- Montomoli E, Pozzi T, Alfonsi V et al. Valutazione benefici/costi della vaccinazione antinfluenzale in una popolazione di soggetti anziani in due stagioni epidemiche a confronto (1999–2000 – 2000/2001) nella Provincia di Siena. Pharmacoeconomics5(Suppl. 1), 31–38 (2002).
- Jensen F, Dittmer S. From influence diagrams to junction tree. In: Proceedings of the Tenth Conference on Uncertainty in Artificial Intelligence. L de Mantras & D Poole (Eds). Morgan Kaufmann Publishers, Edmonton, Canada (1994).
- Claxton K. The irrelevance of inference: a decision-making approach to stochastic evaluation of health care technologies. J. Health Econ.18, 342–364 (1999).
- Claxton K, Schulpher M, McCabe C et al. Probabilistic sensitivity analysis for NICE technology assessments: not an optional extra. Health Econ.14, 339–347 (2005).
Websites
- HUGIN expert www.hugin.com
- Netica www.netica.dk